High Mortality Rate, Early Detection of Lung Cancer Needs to be Improved

CANCER Lung is the most common type of cancer in the world. There are more deaths from lung cancer each year, compared to the total number of deaths from breast, colon, and prostate cancers.

Based on data from the Global Burden of Cancer Study (Globocan) 2020, 34,783 people in Indonesia were diagnosed with lung cancer, with a mortality rate of 30,483. This figure could increase by 43 percent and reach 43,900 cases of death in 2030 if there is no improvement in the diagnosis and management of lung cancer.

Therefore, said the Secretary General of the Indonesian Oncology Association (POI) dr. Evlina Suzanna, Sp. PA. said, early detection is very important to improve the outcome of lung cancer management.

“Early detection is very important to improve the results of lung cancer management. This process cannot be separated from the quality of a comprehensive diagnosis and examination by professional medical personnel,” said Evlina as reported by Antara.

Kanker paru

He said, with the introduction of precision medicine targeting ALK tumors and EGFR positive in lung cancer, there is hope to see an improvement in patient survival without any worsening of the cancer itself.

After diagnosis, the 5-year survival rate in lung cancer patients is low, less than 20 percent based on World Health Organization (WHO) data.

This is largely due to the absence of screening and the fact that two-thirds of new patients consult a doctor with a localized malignant condition or have already metastasized, so that the condition already incurable before being diagnosed.

(mrt)

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Growing Controversy Over 'Skinny' Labeling for Generic Drugs thumbnail

Growing Controversy Over ‘Skinny’ Labeling for Generic Drugs

The vast majority of patients who initiated imatinib therapy for gastrointestinal stromal tumors (GISTs) received a generic drug that did not have FDA approval for that indication, a large retrospective review showed. Almost half of the 2,000 patients in the review of imatinib initiators had chronic myeloid leukemia (CML), while about a third had GIST.…
Read More
Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive thumbnail

Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive

Oncology/Hematology > Other Cancers — News, features, and commentary about cancer-related issues by Charles Bankhead, Senior Editor, MedPage Today April 21, 2023 A federal bankruptcy judge put a hold on about 40,000 lawsuits alleging that Johnson & Johnson's baby powder and other talc-containing products cause cancer, giving J&J subsidiary LTL Management another shot at reaching
Read More

Sobrecarga médica no cenário atual da Covid-19

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed O Portal PEBMED é destinado para médicos e demais profissionais de saúde. Nossos conteúdos informam panoramas recentes da medicina. Caso tenha interesse em divulgar seu currículo na internet,…
Read More
Arginine Starvation Boosts OS in Mesothelioma thumbnail

Arginine Starvation Boosts OS in Mesothelioma

Oncology/Hematology > Lung Cancer — With frontline immunotherapy now standard, strategy could potentially find home in second-line by Elizabeth Short, Staff Writer, MedPage Today February 16, 2024 First-line chemotherapy plus an investigational arginine-depleting agent improved survival in nonepithelioid pleural mesothelioma compared with chemotherapy alone, a randomized trial showed. For the study's primary endpoint, median overall
Read More
KFF Health News' 'What the Health?': Health Funding in Question in a Speaker-Less Congress thumbnail

KFF Health News’ ‘What the Health?’: Health Funding in Question in a Speaker-Less Congress

KFF Health News’ ‘What the Health?’Episode Title: Health Funding in Question in a Speaker-Less CongressEpisode Number: 318Published: Oct. 12, 2023 [Editor’s note: This transcript was generated using both transcription software and a human’s light touch. It has been edited for style and clarity.] Julie Rovner: Hello, and welcome back to “What the Health?” I’m Julie
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share